Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Burkitt Lymphoma 22 Lymphoma, Large B-Cell, Diffuse 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Follicular 12 Lymphoma 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Rhabdomyosarcoma 8 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, B-Cell 6 Leukemia, Biphenotypic, Acute 6 Wilms Tumor 5 Sarcoma, Ewing 5 Recurrence 5 Neuroblastoma 5 Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lymphoma, T-Cell 4 Rhabdomyosarcoma, Embryonal 3 Medulloblastoma 3 Lymphoproliferative Disorders 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Down Syndrome 3 Sarcoma 2 Rhabdomyosarcoma, Alveolar 2 Rhabdoid Tumor 2 Plasmablastic Lymphoma 2 Osteosarcoma 2

Interventions

cabozantinib 5 Nivolumab 4 Ipilimumab 4 Axitinib 4 pembrolizumab 3 Blood Specimen Collection 3 zimberelimab 2 atezolizumab 2 Surveys and Questionnaires 2 Sunitinib 2 Irinotecan 2 temsirolimus 1 spartalizumab 1 salicylhydroxamic acid 1 palbociclib 1 orellanine 1 olaparib 1 liposomal doxorubicin 1 lenvatinib 1 gallium Ga 68 dotatate 1 fludarabine 1 brodalumab 1 belzutifan 1 aldesleukin 1 adagrasib 1 Vincristine 1 Temozolomide 1 Taxes 1 Selenomethionine 1 Ropivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × Vincristine × 90 days × Clear all

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡